These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2574496)

  • 21. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
    Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
    Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical performance and muscle metabolism during beta-adrenergic blockade in man.
    Kaiser P
    Acta Physiol Scand Suppl; 1984; 536():1-53. PubMed ID: 6151777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise.
    Cosenzi A; Sacerdote A; Bocin E; Molino R; Mangiarotti M; Bellini G
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):142-6. PubMed ID: 7723344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
    McLeod AA; Kraus WE; Williams RS
    Am J Cardiol; 1984 Jun; 53(11):1656-61. PubMed ID: 6375340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE; Sims R; Noakes TD
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
    McLeod AA; Knopes KD; Shand DG; Williams RS
    Br J Clin Pharmacol; 1985 Jan; 19(1):13-20. PubMed ID: 2858214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ; Kendall MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat.
    Gordon NF
    Am J Cardiol; 1985 Apr; 55(10):74D-78D. PubMed ID: 3993552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exercise testing, training and beta blockade on serum potassium in normal subjects.
    Fletcher GF; Fletcher BJ; Sweeney ME
    Am J Cardiol; 1990 May; 65(18):1242-5. PubMed ID: 2337035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.
    Stewart WC; Stewart JA; Crockett S; Kubilus C; Brown A; Shams N
    Acta Ophthalmol Scand; 2002 Jun; 80(3):272-6. PubMed ID: 12059865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine-induced hypokalemia: the role of beta adrenoceptors.
    Reid JL; Whyte KF; Struthers AD
    Am J Cardiol; 1986 Apr; 57(12):23F-27F. PubMed ID: 3010693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
    Pringle TH; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenoceptor blockade and exercise. An update.
    Van Baak MA
    Sports Med; 1988 Apr; 5(4):209-25. PubMed ID: 2897710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-adrenergic blockade on supramaximal exercise capacity.
    Schnabel A; Kindermann W; Salas-Fraire O; Cassens J; Steinkraus V
    Int J Sports Med; 1983 Nov; 4(4):278-81. PubMed ID: 6140230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of exercising skeletal muscle during beta 1-selective adrenoceptor blockade.
    Hartling OJ; Schibye B; Klausen K; Lund JO; Trap-Jensen J
    Clin Physiol; 1986 Oct; 6(5):431-8. PubMed ID: 3022982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.